Californians remain concerned about future droughts; Support recycled water as a long-term solution for water security

SACRAMENTO, Calif.–(BUSINESS WIRE)–Apr. 30, 2018– Although 2017 brought significant rainfall to a dry state, Californians remain very concerned about future droughts, and the vast majority support using advanced technologies to generate new water supplies when needed. A statewide survey conducted in late 2017 found that an overwhelming majority of California residents believe another drought is... Read more

QIAGEN announces FDA approval of PartoSure

Germantown, Maryland, and Hilden, Germany, April 20, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. regulatory approval of PartoSure®, which is a novel test for assessing the risk of spontaneous preterm birth in patients with symptoms of preterm labor. The pre-market approval of PartoSure by the U.S. Food and... Read more

New Online Sulfur Analyzer Enables Real-Time Data Analysis in the Oil and Gas Industry

New Online Sulfur Analyzer Enables Real-Time Data Analysis in the Oil and Gas Industry The next-generation Thermo Scientific SOLA iQ total sulfur analyzer is designed for process optimization and offers improved ease-of-use and connectivity over existing analyzers FRANKLIN, Mass., April 18, 2018 /PRNewswire/ — The new Thermo Scientific SOLA iQ online sulfur analyzer helps technicians, engineers... Read more

FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors

Basel, 17 April 2018 FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors Designation based on phase III HAVEN 3 study demonstrating Hemlibra prophylaxis significantly reduced bleeds compared to no prophylaxis First medicine to show superior efficacy compared to prior factor VIII prophylaxis in an intra-patient comparison Roche (SIX: RO, ROG;... Read more

FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors

Basel, 17 April 2018 FDA grants Breakthrough Therapy Designation for Roche’s Hemlibra in haemophilia A without inhibitors Designation based on phase III HAVEN 3 study demonstrating Hemlibra prophylaxis significantly reduced bleeds compared to no prophylaxis First medicine to show superior efficacy compared to prior factor VIII prophylaxis in an intra-patient comparison Roche (SIX: RO, ROG;... Read more

Phenomenex Introduces bioZen Series for Characterization of Biotherapeutics

Torrance, Calif. (April 16, 2018) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces bioZen – a new series of LC solutions for bioseparations in pharmaceutical, biopharmaceutical and academic research. The series encompasses both proven and entirely new media spanning two particle platforms – core-shell... Read more

Sartorius Stedim Biotech and Penn State University announce partnership

University Park, Pennsylvania, USA | Goettingen, Germany, April 16, 2018 – Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders. Part of Sartorius’ investment will be to... Read more

University of Pittsburgh and Thermo Fisher Scientific Establish Pharmacogenomics Center of Excellence

University of Pittsburgh and Thermo Fisher Scientific Establish Pharmacogenomics Center of Excellence Collaboration will support translational research that demonstrates the value of PGx in precision medicine PITTSBURGH, April 5, 2018 /PRNewswire/ — Thermo Fisher Scientific and the University of Pittsburgh have established a new Pharmacogenomics (PGx) Center of Excellence that combines expertise and technology in genomics,... Read more

FDA approves Lucentis (ranibizumab injection) 0.3 mg prefilled syringe for diabetic macular edema and diabetic retinopathy

Basel, 22 March 2018 FDA approves Lucentis (ranibizumab injection) 0.3 mg prefilled syringe for diabetic macular edema and diabetic retinopathy First and only prefilled syringe treatment option FDA-approved to treat all forms of diabetic retinopathy in people with or without diabetic macular edema (DME) Diabetic retinopathy is the leading cause of blindness among adults aged... Read more

WITec Releases TrueMatch – Integrated Raman Spectral Database Software

March 2018 TrueMatch is a powerful and innovative software component for accessing and developing Raman spectral databases WITec, manufacturer of 3D Raman imaging systems, is now offering TrueMatch, a powerful software component for accessing and creating Raman spectral databases. It can search existing libraries of Raman spectra to identify sample components and also allows users... Read more